BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related

Similar documents
Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations

Newborn Genetic Analysis

All diseases on Foresight

Utility of Microarrays in Molecular Genetics

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

General Test Requisition Form - Biochemical and Molecular

For Your Baby s Health Department of Health

CLINICAL AND HUMAN TESTING

Further expansion of the neonatal screening panel in the Netherlands

Foresight Carrier Screen

Joshua Hellmann Foundation - Newborn Metabolic Screening Program

Foresight Carrier Screen

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

General Test Requisition Form - Biochemical and Molecular

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

Foresight Carrier Screen

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

CHRONIC MYELOGENOUS LEUKEMIA

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

Foresight Carrier Screen

Foresight Carrier Screen

Newborn Screening: Focus on Treatment

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Foresight Carrier Screen

Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS

Positive Newborn Screens: What do you do next?

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Residual risks by ethnicity

Foresight Carrier Screen

CARRIER SCREEN - LIST OF DISORDERS

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

GUIDE TO NEWBORN SCREENING PROGRAMME

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS

Newborn Screening in Manitoba. Information for Health Care Providers

Evolve FamilyReady Carrier Screen

Considerations in Choosing Screening Conditions: One (US) Approach

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

NEWBORN METABOLIC SCREEN, MINNESOTA

Joshua Hellmann Foundation - Newborn Metabolic Screening Program

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

devact TM Clinical Management Panel for Neurodevelopmental Disorders

Inborn Errors of Metabolism (IEM)

MetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

Newborn Screening: Blood Spot Disorders

CARRIER SCREENING PANEL

Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence

A Guide for Prenatal Educators

Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:

Expanded carrier screening for monogenic disorders: where are we now?

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Clinical Management of Organic Acidemias and OAA Natural History Registry. Kim Chapman MD PhD Children s National Rare Disease Institute

2015 Annual Report for New Mexico s Newborn Screening (NBS) Program

Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future?

Comprehensive Molecular Testing for Fatty Acid Oxidation Disorders. A Guide for Clinicians

HERES Carrier Screening TEST

Informatics Analysis of Genetic Variants in Newborn Screening By Chelsea Gustafson

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS

Medical Foods for Inborn Errors of Metabolism

Newborn Screening: What s New?

Sequencing in Newborn Screening Introduction and Background

Proposal for EXPANDED NEWBORN SCREENING

Newborn Screening in Washington State Saving lives with a simple blood spot

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

4978 Santa Anita Ave Temple City, CA (p) (f)

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

Results Recipient Ordering Healthcare Professional Male Details Female Details

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory

Approach to diagnosis of metabolic diseases

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

BCM 225 LECTURE ON INBORN ERRORS OF METABOLISM OJEMEKELE O.

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment

What s New in Newborn Screening?

Transcription:

Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy 300371 300100 Miscellaneous multisystem diseases ABCD4 ACAD8 ACAD9 ACADM ACADS Methylmalonic aciduria and homocystinuria, cblj type Isobutyryl-CoA dehydrogenase acyl-coa dehydrogenase-9 (ACAD9) Acyl-CoA dehydrogenase, medium chain, of Acyl-CoA dehydrogenase, short-chain, of 603214 614857 Metabolic disorder - 604773 611283 Metabolic Disorder - 611103 611126 Metabolic Disorder - fatty acid 607008 201450 Metabolic Disorder - fatty acid 606885 201470 Metabolic Disorder - fatty acid ACADSB 2-methylbutyrylglycinuria 600301 610006 Metabolic Disorder - ACADVL ACAT1 ACSF3 very long-chain acyl-coa dehydrogenase Alpha-methylacetoacetic aciduria Combined malonic and methylmalonic aciduria 609575 201475 Metabolic Disorder - fatty acid 607809 203750 Metabolic Disorder - 614245 614265 Metabolic Disorder - * ** 1

ADA ADK AGL Severe combined immuno due to ADA Hypermethioninemia due to adenosine kinase Glycogen storage disease, type III 608958 102700 Primary 102750 614300 Metabolic Disorder - 610860 232400 Other Disorders AGXT Primary hyperoxaluria, type 1 604285 259900 AHCY Hypermethioninemia with of S- adenosylhomocysteine hydrolase 180960 613752 Metabolic Disorder - AK2 Reticular dysgenesis 103020 267500 Primary AKR1D1 Bile acid synthesis defect, congenital, 3 604741 235555 ALDH4A1 Hyperprolinemia, type II 606811 239510 Metabolic disorder - ALDH7A1 ALDOB Epilepsy, pyridoxinedependent Fructose intolerance, hereditary ALPL Hypophosphatasia 171760 241500 107323 266100 Neurotransmitter Disorders 612724 229600 Metabolic Disorder - ANK1 Spherocytosis, type 2 612641 182900 AQP2 Diabetes insipidus, nephrogenic 107777 125800 2

ARG1 Argininemia 608313 207800 Metabolic Disorder - ARSA Metachromatic leukodystrophy 607574 250100 Lysosomal Storage ARSB Mucopolysaccharidosis type VI (Maroteaux-Lamy) 611542 253200 Lysosomal Storage ASL Argininosuccinic aciduria 608310 207900 Metabolic Disorder - ASS1 Citrullinemia Type 1 603470 215700 Metabolic Disorder - AUH AVPR2 BCKDHA BCKDHB 3-methylglutaconic aciduria, type I Nephrogenic syndrome of inappropriate antidiuresis / Nephrogenic diabetes insipidus AVPR2-related Maple syrup urine disease, type Ia Maple syrup urine disease, type Ib 600529 250950 Metabolic Disorder - 300538 300539 608348 248600 Metabolic Disorder - 248611 248600 Metabolic Disorder - BTD Biotinidase 609019 253260 Miscellaneous multisystem diseases BTK Agammaglobulinemia, X- linked 1 CASR Neonatal hyperparathyroidism / Autosomal dominant hypocalcemia 300300 300755 Primary 601199 601198 Endocrine Disorder 3

CBS Homocystinuria, B6- responsive and nonresponsive types 613381 236200 Metabolic Disorder - CD247 Immuno 25 186780 610163 Primary CD320 Methylmalonic aciduria, transient, due to transcobalamin receptor defect 606475 613646 Metabolic Disorder - CD3D Immuno 19 186790 615617 Primary CD3E Immuno 18 186830 615615 Primary CFTR Cystic fibrosis 602421 219700 Miscellaneous multisystem diseases COL4A3 Alport syndrome COL4A3-120070 104200 related COL4A4 Alport syndrome, autosomal recessive 120131 203780 COL4A5 Alport syndrome 303630 301050 CPS1 CPT1A CPT2 Carbamoylphosphate synthetase I Carnitine palmitoyltransferase type I Carnitine palmitoyltransferase type II 608307 237300 Metabolic Disorder - 600528 255120 Metabolic Disorder - fatty acid 600650 255110 Metabolic Disorder - fatty acid CTH Cystathioninuria 607657 219500 Metabolic Disorder - 4

CTNS Cystinosis 606272 219800 Lysosomal Storage CYBA CYBB CYP11B1 CYP11B2 Chronic granulomatous disease, autosomal, due to of CYBA Chronic granulomatous disease CYBB-related Congenital adrenal hyperplasia due to 11-betahydroxylase Corticosterone methyloxidase 608508 233690 300481 306400 610613 202010 Endocrine Disorder 124080 610600 CYP21A2 CYP27A1 Adrenal hyperplasia, congenital, due to 21- hydroxylase Cerebrotendinous xanthomatosis 613815 201910 Endocrine Disorder 606530 213700 Other Disorders DBT DCLRE1C DECR1 DLD Maple syrup urine disease, type II Omenn syndrome / Severe combined immuno, Athabaskan-type 2,4-dienoyl-CoA reductase Dihydrolipoamide dehydrogenase 248610 248600 Metabolic Disorder - 605988 603554 Primary 222745 Metabolic Disorder - fatty acid 238331 246900 Metabolic Disorder - Organic Acidemias DNAJC19 DUOX2 Hyperphenylalaninemia, mild, non-bh4-deficient Thyroid dyshormonogenesis 6 606060 617384 Metabolic Disorder - 606759 607200 Endocrine Disorder 5

DUOXA2 Thyroid dyshormonogenesis 5 612772 274900 Endocrine Disorder EPB42 Spherocytosis, type 6 177070 612690 ETFA Glutaric acidemia IIA 608053 231680 Metabolic Disorder - fatty acid ETFB Glutaric acidemia IIB 130410 231680 Metabolic Disorder - fatty acid ETFDH Glutaric acidemia IIC 231675 231680 Metabolic Disorder - fatty acid ETHE1 Ethylmalonic encephalopathy 608451 602473 Metabolic Disorder - Organic Acidemias F9 Factor IX 300746 300807 FAH Tyrosinemia, type I 613871 276700 Metabolic Disorder - FBN1 Marfan syndrome and 134797 154700 other FBN1-related disorders FBP1 Fructose-1,6- bisphosphatase 611570 229700 Metabolic Disorder - Organic Acidemias FOLR1 FTCD G6PC G6PD Neurodegeneration due to cerebral folate transport Glutamate formiminotransferase Glycogen storage disease, type Ia Hemolytic anemia, G6PD deficient (favism) 136430 613068 Other Disorders 606806 229100 Metabolic Disorder - Organic Acidemias 613742 232200 Metabolic Disorder - 305900 300908 Miscellaneous multisystem diseases 6

GAA Glycogen storage disease II - Pompe disease 606800 232300 Lysosomal Storage GALC Krabbe disease 606890 245200 Lysosomal Storage GALE GALK1 Galactose epimerase Galactokinase with cataracts 606953 230350 Miscellaneous multisystem diseases 604313 230200 Miscellaneous multisystem diseases GALNS Mucopolysaccharidosis IVA 612222 253000 Lysosomal Storage GALT Galactosemia 606999 230400 Miscellaneous multisystem diseases GAMT Cerebral creatine 601240 612736 syndrome 2 GATM Cerebral creatine syndrome 602360 612718 GBA Gaucher disease, type I 606463 230800 Lysosomal Storage GCDH Glutaricaciduria, type I 608801 231670 Metabolic Disorder - GCH1 GJB2 GJB3 GJB6 Hyperphenylalaninemia, BH4-deficient, B Deafness, autosomal recessive 1A Deafness, digenic, GJB2/GJB3 Deafness, digenic GJB2/GJB6 600225 233910 Metabolic Disorder - 121011 220290 Deafness 603324 220290 Deafness 604418 220290 Deafness GLA Fabry disease 300644 301500 Lysosomal Storage GLIS3 Diabetes mellitus, neonatal, with congenital hypothyroidism 610192 610199 Endocrine Disorder 7

GLUD1 GNAS GNAS GNAS congenital hyperinsulinic hyperammonemia (HI/HA) syndrome Pseudohypoparathyroidism Ia Pseudohypoparathyroidism Ib Pseudohypoparathyroidism Ic 138130 606762 Endocrine Disorders 139320 103580 Endocrine Disorders 139320 603233 Endocrine Disorders 139320 612462 Endocrine Disorders GNAS Pseudopseudohypoparathyr oidism 139320 612463 Endocrine Disorders GNMT Glycine N- methyltransferase GRHPR GSS Hyperoxaluria, primary, type II Glutathione synthetase - 5-oxoprolinuria GYS2 Glycogen storage disease 0, liver HADH HADHA HADHA HADHB Short-chain hydroxyacylcoenzyme A dehydrogenase long-chain hydroxyacyl-coa dehydrogenase Trifunctional protein Trifunctional protein 606628 606664 Metabolic Disorder - 604296 260000 Metabolic Disorder - 601002 266130 Metabolic Disorder - 138571 240600 Metabolic Disorder - 601609 231530 Metabolic Disorder - fatty acid 600890 609016 Metabolic Disorder - fatty acid 600890 609015 Metabolic Disorder - fatty acid 143450 609015 Metabolic Disorder - fatty acid 8

HAL Histidinemia 609457 235800 Metabolic Disorder - HAX1 Neutropenia, severe congenital 3, autosomal recessive 605998 610738 HBA1 Thalassemia, alpha- 141850 604131 Hemoglobinopathies HBA2 Thalassemia, alpha- 141850 604131 Hemoglobinopathies HBB Sickle cell anemia 141900 603903 Hemoglobinopathies HBB Thalassemias, beta- 141900 613985 Hemoglobinopathies HGD Alkaptonuria 607474 203500 Metabolic Disorder - HLCS Holocarboxylase synthetase 609018 253270 Metabolic Disorder - HMGCL HMG-CoA lyase 613898 246450 Metabolic Disorder - HMGCS2 HOGA1 HMG-CoA synthase-2 Hyperoxaluria, primary, type III 600234 605911 Metabolic Disorder - fatty acid 613597 613616 HPD Tyrosinemia, type III 609695 276710 Metabolic Disorder - HSD17B10 HSD3B2 17-beta-hydroxysteroid dehydrogenase X (HSD10) Adrenal hyperplasia, congenital, due to 3-betahydroxysteroid dehydrogenase 2 300256 300438 Metabolic Disorder - Organic Acidemias 613890 201810 Endocrine Disorder 9

HSD3B7 Bile acid synthesis defect, congenital, 2 607764 607765 IDS Mucopolysaccharidosis II 300823 309900 Lysosomal Storage IDUA IL2RG IL7R INS Mucopolysaccharidosis type Ih Severe combined immuno, X-linked Severe combined immuno, T-cell negative, B-cell/natural killer cell-positive type Diabetes mellitus, permanent neonatal 252800 607014 Lysosomal Storage 308380 300400 Primary 146661 608971 Primary 176730 606176 Endocrine Disorder IVD Isovaleric acidemia 607036 243500 Metabolic Disorder - IYD Thyroid dyshormonogenesis 612025 274800 Endocrine Disorder 5 JAG1 Alagille syndrome 1 / Tetralogy of Fallot 601920 118450 Endocrine Disorder JAK3 Severe combined immuno 600173 600802 Primary KCNJ11 Familial hyperinsulinism 600937 601820 Endocrine Disorder KCNQ2 LDLR LHX3 Early Infantile epileptic encephalopathy 7 / Benign neonatal seizures 2 Familial hypercholesterolemia Combined pituitary hormone 4 602235 613720 Other Disorders 606945 143890 Endocrine Disorder 600577 221750 Endocrine Disorder 10

LIG4 LIG4 syndrome 601837 606593 Primary LIPA Wolman disease / Cholesteryl ester storage disease LMBRD1 Methylmalonic aciduria and homocystinuria, cblf type LPL Lipoprotein lipase 609708 238600 613497 278000 Lysosomal Storage 612625 277380 Metabolic Disorder - MAT1A MCCC1 MCCC2 MCEE Hypermethioninemia, due to methionine adenosyltransferase I/III 3-Methylcrotonyl-CoA carboxylase 1 3-Methylcrotonyl-CoA carboxylase 2 Methylmalonyl-CoA epimerase 610550 250850 Metabolic Disorder - 609010 210200 Metabolic Disorder - 609014 210210 Metabolic Disorder - 608419 251120 Metabolic Disorder - Organic Acidemias MLYCD MMAA MMAB MMACHC Malonyl-CoA decarboxylase Methylmalonic aciduria, vitamin B12-responsive Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblb complementation type Methylmalonic aciduria and homocystinuria, cblc type 606761 248360 Metabolic Disorder - 607481 251100 Metabolic Disorder - 607568 251110 Metabolic Disorder - 609831 277400 Metabolic Disorder - 11

MMADHC MPI Methylmalonic aciduria and homocystinuria, cbld type Congenital disorder of glycosylation, type Ib 611935 277410 Metabolic Disorder - 154550 602579 MPL Congenital amegakaryocytic thrombocytopenia 159530 604498 MTHFR MTR MTRR Homocystinuria due to MTHFR Homocystinuriamegaloblastic anemia, cobalamin G type Homocystinuria, cobalamin E type MTTP Abetalipoproteinemia 157147 200100 607093 236250 Metabolic Disorder - 156570 250940 Metabolic Disorder - 602568 236270 Metabolic Disorder - MUT Methylmalonic aciduria, mut(0) type 609058 251000 Metabolic Disorder - MVK Mevalonic aciduria 251170 610377 Metabolic Disorder - NADK2 NAGS NHEJ1 2,4-dienoyl-CoA reductase N-acetylglutamate synthase Severe combined immuno with microcephaly, growth retardation, and sensitivity to ionizing radiation 615787 616034 Metabolic Disorder - fatty acid 608300 237310 Metabolic Disorder - 611290 611291 Primary 12

NKX2-1 NKX2-5 NPC1 NPC2 Choreoathetosis, hypothyroidism, and neonatal respiratory distress Hypothyroidism, congenital nongoitrous, 5 Niemann-Pick disease, type C1 Niemann-pick disease, type C2 600635 610978 Endocrine Disorder 600584 225250 Endocrine Disorder 607623 257220 Lysosomal Storage 601015 607625 Lysosomal Storage OAT OPA3 OTC Gyrate atrophy of choroid and retina with or without ornithinemia 3-methylglutaconic aciduria, type III Ornithine transcarbamylase 613349 258870 Metabolic Disorder - 606580 258501 Metabolic Disorder - 300461 311250 Metabolic Disorder - PAH Phenylketonuria 612349 261600 Metabolic Disorder - PAX8 PC Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia Pyruvate carboxylase 167415 218700 Endocrine Disorder 608786 266150 PCBD1 Hyperphenylalaninemia, BH4-deficient, D 126090 264070 Metabolic Disorder - PCCA Propionic acidemia 232000 606054 Metabolic Disorder - PCCB Propionic acidemia 232050 606054 Metabolic Disorder - 13

PHGDH PHKB PNP PNPO POU1F1 3-phosphoglycerate dehydrogenase Glycogen storage disease, type IXb Immuno due to purine nucleoside phosphorylase Pyridoxamine 5 -phosphate oxidase Combined pituitary hormone 1 606879 601815 Metabolic Disorder - 172490 261750 Other Disorders 164050 613179 Primary 603287 610090 173110 613038 Endocrine Disorder PPARG PRF1 peroxisome proliferator activated receptorgamma (PPAR-g) ligand resistance syndrome (PLRS) or familial partial lipodystrophy type 3 Hemophagocytic lymphohistiocytosis, familial, 2 601487 604367 170280 603553 Primary PRODH Hyperprolinemia, type I 606810 239500 Metabolic Disorder - PROP1 Combined pituitary hormone 2 601538 262600 Endocrine Disorder PRRT2 PTPRC PTS Familial infantile convulsions with paroxysmal choreoathetosis Severe combined immuno PTPRCrelated Hyperphenylalaninemia, BH4-deficient, A 614386 602066 Other Disorders 151460 608971 Primary 612719 261640 Metabolic Disorder - 14

PYGL Glycogen storage disease, type VI 613741 232700 Other Disorders QDPR RAG1 RAG2 Hyperphenylalaninemia, BH4-deficient, C Omenn syndrome and other RAG1-related disorders Omenn syndrome RAG2- related 612676 261630 Metabolic Disorder - 179615 603554 Primary 179616 603554 Primary RB1 Retinoblastoma 614041 180200 Other Disorders SCN2A SCN8A SLC22A5 SLC25A13 SLC25A15 SLC25A20 Early infantile epileptic encephalopathy 11 / Benign familial infantile seizures 3 Early infantile epileptic encephalopathy 13 / Benign familial infantile seizures 5 Carnitine, systemic primary Citrullinemia, type II, adultonset - neonatal-onset Hyperornithinemiahyperammonemiahomocitrullinemia syndrome Carnitine-acylcarnitine translocase 182390 613721 Other Disorders 600702 614558 Other Disorders 603377 212140 Metabolic Disorder - fatty acid 603859 603471 Metabolic Disorder - 603861 238970 Metabolic Disorder - 613698 212138 Metabolic Disorder - fatty acid SLC26A4 Pendred syndrome 605646 274600 Deafness SLC26A4 Deafness, autosomal recessive 4, with enlarged vestibular aqueduct 605646 600791 Deafness 15

SLC2A1 Glucose transporter 1 138140 606777 syndrome and other SLC2A1-related disorders SLC37A4 Glycogen storage disease Ib 602671 232220 Lysosomal Storage SLC37A4 Glycogen storage disease Ic 602671 232240 Lysosomal Storage SLC39A4 Acrodermatitis enteropathica 607059 201100 SLC3A1 Cystinuria 104614 220100 Metabolic Disorder - SLC4A1 Distal renal tubular acidosis and other SLC4A1-related disorders 109270 179800 SLC5A5 Thyroid dyshormonogenesis 1 601843 274400 Endocrine Disorder SLC7A7 Lysinuric protein intolerance 603593 222700 SLC7A9 Cystinuria 604144 220100 Metabolic Disorder - SMPD1 SMPD1 SPR Niemann-Pick disease, type A Niemann-Pick disease, type B Sepiapterin reductase STAR Lipoid adrenal hyperplasia 600617 201710 607608 257200 Lysosomal Storage 607608 607616 Lysosomal Storage 182125 612716 Metabolic Disorder - STX11 Hemophagocytic lymphohistiocytosis, familial, 4 605014 603552 Primary 16

SUCLA2 SUCLG1 Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic 603921 612073 Metabolic Disorder - Organic Acidemias 611224 245400 Metabolic Disorder - Organic Acidemias aciduria) TAT Tyrosinemia, type II 613018 276600 Metabolic Disorder - TAZ 3-methylglutaconic aciduria, type II - Barth syndrome TCIRG1 Osteopetrosis 1 604592 259700 300394 302060 Metabolic Disorder - TG Thyroid dyshormonogenesis 4 188450 274700 Endocrine Disorder TH Segawa syndrome 191290 605407 THRA TMEM70 TPO Congenital nongoitrous hypothryoidism 6 Mitochondrial complex V (ATP synthase), nuclear type 2 Thyroid dyshormonogenesis 2A 190120 614450 Endocrine Disorder 612418 614052 Metabolic Disorder - Organic Acidemias 606765 274500 Endocrine Disorder TRHR Generalized thyrotropinreleasing hormone resistance 188545 TRMU Acute infantile liver failure 610230 613070 17

TSHB Congenital nongoitrous hypothryoidism 4 188540 275100 Endocrine Disorder TSHR TTPA Hypothyroidism, congenital, nongoitrous, 1 Ataxia with isolated vitamin E 603372 275200 Endocrine Disorder 600415 277460 Other Disorders UNC13D WT1 Hemophagocytic lymphohistiocytosis, familial, 3 Wilms tumor, type 1 and other WT1-related disorders 608897 608898 Primary 607102 194070 ZAP70 Immuno 48 176947 269840 Primary * : Recommended Uniform Screening Panel - Core Conditions ACOG Committee Opinion 616 Jan 2015 ** : Recommended Uniform Screening Panel - Secondary Conditions ACOG Committee Opinion 616 Jan 2015 18

BabyNEXT TM Farmacogenetica Lista dei geni analizzati e dei farmaci metabolizzati dai rispettivi enzimi Gene Drugs OMIM gene CYP1A2 Phenacetin 124060 CYP2C19 Amitriptyline, Citalopram, Clomipramine, Doxepin, Escitalopram, 124020 Sertraline, Trimipramine, Clopidogrel, Voriconazole CYP2C9 Celecoxib, Warfarin, Fosphenytoin, Phenytoin 601130 CYP2D6 Codeine, Hydrocodone, Oxycodone, Tramadol, Ondansetron, 124030 Amitriptyline, Clomipramine, Desipramine, Doxepin, Fluoxetine, Fluvoxamine, Imipramine, Notriptyline, Paroxetine, Trimipramine, Aripiprazole, Iloperidone, Pimozide, Eliglustat, Atomoxetine CYP3A4 Imipramine, Amitriptyline, Sertraline, Venlafaxine, Nefazodone, 124010 Alprazolam, Triazolam, Midazolam, Ketoconazole, Itraconazole, Fluconazole, Astemizole, Ritonavir, Indinavir, Nelfinavir, Saquinavir, Carbamazepine, Dexamethasone, Phenobarbital, Phenytoin, Rifampicin, Terfenadine, Verapamil, Testosterone, Theophylline, Carbamazepine, Cisapride, Dexamethasone, Eritromicina, Ethinyl estradiol, Glyburide, Cyclosporin, Lovastatin CYP3A5 Tacrolimus 605325 CYP3A7 responsible for the of more than 50% of all clinically used 605340 drugs DPYD Capecitabine 612779 SLCO1B1 Simvastatin 604843 TPMT Mercaptopurine, Thioguanine, Azathioprine 187680 UGT1A1 Atazanavir 191740 VKORC1 Warfarin 608547 19